They also found that aspirin lead to greater reduction in new infarcts and mortality by day 60 as compared to placebo and the reduction was higher in high dose aspirin (1000 mg) than low dose aspirin (81 mg) [34.4% events in placebo versus 14.8% in low dose aspirin 81 mg versus 10.7% in high dose aspirin 1000 mg]; although the difference did not reach statistical significance [6] .
← all excerpts
Efficacy and safety of aspirin as an adjunctive therapy in tubercular meningitis: A systematic review and meta-analysis.
1
—
—